phenylalanine has been researched along with tretinoin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avdeef, A; Tam, KY | 1 |
Barrett, AJ; Buttle, DJ; Handley, CJ; Ilic, MZ; Murata, M; Saklatvala, J | 1 |
Ismair, MG; Liu, H; Petrides, PE; Ries, C; Zang, C | 1 |
Colige, A; Devy, L; Foidart, JM; Garnotel, R; Hollender, P; Jeannesson, P; Munaut, C; Noël, A | 1 |
Bayliss, MT; Bird, JL; Mason, RM; Sugimoto, K; Yasumoto, T | 1 |
Hirose, M; Jingami, H; Kitano, J; Moriyoshi, K; Muto, T; Nakajima, Y; Nakanishi, S; Yamamura, H; Yanagi, S | 1 |
Dansette, PM; Jaouen, M; Johnson, EF; Macherey, AC; Mansuy, D; Marques-Soares, C; Melet, A; Sari, MA; Schoch, GA | 1 |
Cheng, M; Hao, F; Jin, S; Jing, Y; Li, F; Liu, G; Ren, J; Zhao, D | 1 |
Chen, F; Tang, J; Wang, T; Wang, X; Zhou, J | 1 |
Seagraves, NJ; Watson, JN | 1 |
10 other study(ies) available for phenylalanine and tretinoin
Article | Year |
---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation.
Topics: Aggrecans; Amino Acid Sequence; Animals; Cartilage; Cartilage, Articular; Cathepsin B; Cattle; Dipeptides; Enzyme Activation; Extracellular Matrix Proteins; Interleukin-1; Lectins, C-Type; Metalloendopeptidases; Molecular Sequence Data; Nasal Septum; Peptide Fragments; Phenylalanine; Proteoglycans; Recombinant Proteins; Thiophenes; Tretinoin | 1993 |
Enhanced migration of the acute promyelocytic leukemia cell line NB4 under in vitro conditions during short-term all-trans-retinoic acid treatment.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Cell Adhesion; Cell Line; Cell Movement; Cell Separation; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Extracellular Matrix; Flow Cytometry; Fluorescence; Gelatinases; Humans; Integrins; Laminin; Leukemia, Promyelocytic, Acute; Matrix Metalloproteinase Inhibitors; Phenylalanine; Proteoglycans; Thiophenes; Time Factors; Tretinoin | 2000 |
Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid.
Topics: Aclarubicin; Antineoplastic Agents; Cell Differentiation; Cell Movement; HL-60 Cells; Humans; Leukemia; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Phenylalanine; Serine Endopeptidases; Thiophenes; Tissue Inhibitor of Metalloproteinases; Tretinoin; Tumor Cells, Cultured | 2002 |
The G1 domain of aggrecan released from porcine articular cartilage forms stable complexes with hyaluronan/link protein.
Topics: Aggrecans; Animals; Antibody Specificity; Cartilage, Articular; Culture Media, Conditioned; Culture Techniques; Endopeptidases; Extracellular Matrix Proteins; Glycosaminoglycans; Hyaluronic Acid; Immune Sera; Interleukin-1; Lectins, C-Type; Metalloendopeptidases; Peptide Fragments; Phenylalanine; Protease Inhibitors; Proteoglycans; Rabbits; Swine; Thiophenes; Tretinoin | 2003 |
Phosphorylation and recruitment of Syk by immunoreceptor tyrosine-based activation motif-based phosphorylation of tamalin.
Topics: Alternative Splicing; Amino Acid Motifs; Animals; Brain; Carrier Proteins; Cell Line; Cell Membrane; COS Cells; CSK Tyrosine-Protein Kinase; DNA; DNA Mutational Analysis; DNA, Complementary; Enzyme Precursors; Immunoblotting; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Models, Genetic; Mutation; Phenylalanine; Phosphorylation; Precipitin Tests; Protein Structure, Tertiary; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Rats; Signal Transduction; src-Family Kinases; Syk Kinase; Transfection; Tretinoin; Tyrosine | 2004 |
Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
Topics: Amiodarone; Animals; Arginine; Aryl Hydrocarbon Hydroxylases; Asparagine; Catalysis; Chromans; Computer Simulation; Cytochrome P-450 CYP2C8; Diclofenac; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Isoleucine; Models, Molecular; Mutagenesis, Site-Directed; Paclitaxel; Phenylalanine; Rabbits; Serine; Substrate Specificity; Sulfonamides; Thiazolidinediones; Tretinoin; Troglitazone | 2004 |
2-(2-Methylfuran-3-carboxamido)-3-phenylpropanoic acid, a potential CYP26A1 inhibitor to enhance all-trans retinoic acid-induced leukemia cell differentiation based on virtual screening and biological evaluation.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Synergism; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Phenylalanine; Retinoic Acid 4-Hydroxylase; Tretinoin | 2013 |
In vivo pharmacokinetics, biodistribution and antitumor effect of amphiphilic poly(L-amino acids) micelles loaded with a novel all-trans retinoic acid derivative.
Topics: Amino Acids; Animals; Antineoplastic Agents; Apoptosis; Area Under Curve; Aspartic Acid; Cell Line, Tumor; Drug Delivery Systems; Humans; Male; Mice; Mice, Inbred BALB C; Micelles; Phenylalanine; Polymers; Rats; Rats, Sprague-Dawley; Retinoids; Solubility; Tissue Distribution; Tretinoin | 2014 |
RNA-Seq analysis in an avian model of maternal phenylketonuria.
Topics: Animals; Chickens; Disease Models, Animal; Female; Heart Defects, Congenital; Metabolic Networks and Pathways; Phenotype; Phenylalanine; Phenylketonuria, Maternal; Pregnancy; Sequence Analysis, RNA; Transcriptome; Tretinoin; Zygote | 2019 |